MGA031, Sirolimus and Tacrolimus in Islet Transplantation

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

May 31, 2010

Study Completion Date

June 30, 2010

Conditions
Type 1 Diabetes MellitusHypoglycemia
Interventions
BIOLOGICAL

Allogeneic Islets of Langerhans

Intraportal infusion of islets of Langerhans

Trial Locations (1)

55455

University of Minnesota, Minneapolis

Sponsors
All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

Juvenile Diabetes Research Foundation

OTHER

lead

University of Minnesota

OTHER